FNB:NYSEF.N.B. Corporation Analysis
Data as of 2026-09-30 - not real-time
$17.32
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
F.N.B. Corporation trades at $17.32, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 10.7% over the past 30 days. With RSI at 33.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. The recent range runs from support at $17.22 up to resistance at $18.72.
On valuation the read is undervalued — earnings multiple of 10.3 versus a 15.3 sector average, below the peer group. Sell-side targets cluster 20.9% above the current quote. Revenue is growing at 6.8% on a 34.6% profit margin. The 2.98% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 18.9%, a beta of 0.84 and a maximum drawdown of 16.3%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
On valuation the read is undervalued — earnings multiple of 10.3 versus a 15.3 sector average, below the peer group. Sell-side targets cluster 20.9% above the current quote. Revenue is growing at 6.8% on a 34.6% profit margin. The 2.98% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 18.9%, a beta of 0.84 and a maximum drawdown of 16.3%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Top Market Events
F.N.B. Corporation Reports Second Quarter 2026 Earnings PR Newswire PITTSBURGH, July 16, 2026 Record Revenue of $462.7...Record Revenue of $462.7 million Drove EPS Growth of 16.7% Year-Over-Year PITTSBURGH, July 16, 2026 /PRNewswire/ --...F N B Corp FNB reports a 17% increase in EPS and record revenue, while navigating competitive deposit markets and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 17.88
- MACD momentum is negative
- 30-day price change of -10.7%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 10.3 versus sector average of 15.3
- Trading below the 200-day average of 17.88
- Analyst targets imply +20.9% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 10.3 versus sector average of 15.3
- Analyst targets imply +20.9% versus the current price
- Profit margin of 34.6% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin34.62%
P/E Ratio10.3
ROE9.04%
ROA1.20%
P/B Ratio0.9
Op. Cash Flow$704.0M
Industry P/E15.3
Technical Analysis
TrendNeutral
RSI33.7
Support$17.22
Resistance$18.72
MA 20$17.97
MA 50$18.53
MA 200$17.88
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Fair Value$14.35
Target Price$20.94
Upside/Downside20.93%
GradeUndervalued
TypeValue
Dividend Yield2.98%
Risk Assessment
Beta0.84
Volatility18.91%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.